1. AB0186 Elevated Indoleamine-2, 3-Dioxygenase (IDO) and Tryptophan Catabolism in Primary SjÖGren's Syndrome Patients, Positive for the Interferon Type I Signature: A Possible Link to Fatigue and Depression. (10th June 2014) Authors: Maria, N.I.; van Helden-Meeuwsen, C.G.; Brkic, Z.; van Daele, P.L.; van Hagen, M.; Gibney, S.M.; Harkin, A.; Drexhage, H.A.; Versnel, M.A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibitors of the NMDA-Nitric Oxide Signaling Pathway Protect Against Neuronal Atrophy and Synapse Loss Provoked by l-alpha Aminoadipic Acid-treated Astrocytes. (10th November 2018) Authors: David, J.; O'Toole, E.; O'Reilly, K.; Thuery, G.; Assmann, N.; Finlay, D.; Harkin, A. Journal: Neuroscience Issue: Volume 392(2018) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons. (20th August 2015) Authors: Doucet, M.V.; O'Toole, E.; Connor, T.; Harkin, A. Journal: Neuroscience Issue: Volume 301(2015) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons. (20th August 2015) Authors: Doucet, M.V.; O'Toole, E.; Connor, T.; Harkin, A. Journal: Neuroscience Issue: Volume 301(2015) Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗